Clinical Trial Update: Evaluation of the Safety and Potential Therapeutic Effects of CB-AC-02 in Patients With Alzheimer's Disease [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update evaluating safety and potential therapeutic effects of CB-AC-02 in Alzheimer's disease across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• CB-AC-02

Snippet

Sponsor: CHABiotech CO., Ltd | Conditions: Alzheimer's Disease | Phase 1, Phase 2 | Status: UNKNOWN